Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial - BCPP/Ya Tsie trial.
Lerato E MagosiYinfeng ZhangTanya GolubchikVictor DeGruttolaEric Tchetgen TchetgenVladimir NovitskyJanet MoorePam BachanasTebogo SegolodiRefeletswe LebelonyaneMolly Pretorius HolmeSikhulile MoyoJoseph MakhemaShahin LockmanChristophe FraserMyron Max EssexMarc Lipsitchnull nullPublished in: eLife (2022)
This study was supported by the National Institute of General Medical Sciences (U54GM088558), the Fogarty International Center (FIC) of the U.S. National Institutes of Health (D43 TW009610), and the President's Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention (CDC) (Cooperative agreements U01 GH000447 and U2G GH001911).
Keyphrases
- healthcare
- antiretroviral therapy
- public health
- phase iii
- study protocol
- quality improvement
- phase ii
- clinical trial
- hiv infected
- growth hormone
- hiv positive
- human immunodeficiency virus
- emergency department
- hiv aids
- hepatitis c virus
- mental health
- hiv testing
- cell cycle
- open label
- randomized controlled trial
- health information
- risk assessment
- cell proliferation
- health promotion
- combination therapy
- south africa
- climate change